Sentinel Trust Co. LBA Has $204,000 Stock Holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Sentinel Trust Co. LBA decreased its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 12.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,191 shares of the company’s stock after selling 1,999 shares during the period. Sentinel Trust Co. LBA’s holdings in BlackRock Health Sciences Term Trust were worth $204,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of BMEZ. Brown Brothers Harriman & Co. bought a new stake in BlackRock Health Sciences Term Trust during the third quarter worth $32,000. K2 Principal Fund L.P. acquired a new position in shares of BlackRock Health Sciences Term Trust during the 3rd quarter worth about $158,000. Jane Street Group LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the 3rd quarter valued at about $357,000. Kingswood Wealth Advisors LLC acquired a new stake in BlackRock Health Sciences Term Trust in the 4th quarter valued at about $420,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in BlackRock Health Sciences Term Trust during the fourth quarter worth about $471,000.

BlackRock Health Sciences Term Trust Price Performance

Shares of NYSE BMEZ opened at $15.68 on Friday. The business’s 50 day moving average price is $15.64 and its two-hundred day moving average price is $15.68. BlackRock Health Sciences Term Trust has a twelve month low of $14.27 and a twelve month high of $16.75.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, February 28th. Investors of record on Friday, February 14th will be issued a dividend of $0.1773 per share. This represents a $2.13 dividend on an annualized basis and a dividend yield of 13.57%. The ex-dividend date of this dividend is Friday, February 14th.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.